Center News

Former and current global business, government, and public health leaders will play a team of high-level decision makers convened to recommend actions to diminish the large-scale economic and societal consequences of a fictional outbreak of a severe pandemic scenario in the upcoming Event 201.

The Johns Hopkins Center for Health Security was commissioned by the Global Preparedness Monitoring Board (GPMB) to assess the state of readiness for a high-impact respiratory pathogen pandemic.

The Johns Hopkins Center for Health Security in partnership with the World Economic Forum and the Bill and Melinda Gates Foundation will host a global pandemic exercise called “Event 201” on Friday, October 18, 2019, in New York City.

The Center for Health Security and the Tianjin University Center for Biosafety Research and Strategy co-hosted an event that brought together leading experts and emerging leaders from China and the US to discuss the ways that synthetic biology may alter the social and economic frameworks of modern humanity.

The Johns Hopkins Center for Health Security and Gingko Bioworks convened key science, technical, academic, and industry experts for a meeting to solicit stakeholder input on specific ways that national policy can strengthen the US bioeconomy.

Gigi Gronvall, PhD, and her colleagues, Diane DiEuliis, PhD, and Amanda Moodie, MA, scholars at the Center for the Study of Weapons of Mass Destruction, prepared a document to be submitted to the Biological Weapons Convention (BWC) by the United States at the Meeting of Experts on Review of developments in the field of science and technology.

Experts from the Center for Health Security are honored to participated in and present at the upcoming Global Health Security 2019 conference in Sydney, Australia, June 18-20.

The Center recently co-hosted the 2019 meeting of the Strategic Multilateral Dialogue on Biosecurity with the Thailand Ministry of Public Health Department of Disease Control in Phuket, Thailand.

To date, the pharmaceutical response to emerging infectious diseases and bioterrorism has been characterized by a “one bug, one drug” approach, where specific medical countermeasures—effective vaccines and therapeutics—are developed, manufactured, and deployed, explain experts in a new report from the Center for Health Security.

A new report by a team of researchers at the Center for Health Security reframes the discussion of the most severe biological threats to provide policy advocates with an additional tool to help them catalyze expansive international support for work on pandemic prevention and response.